Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.17
-0.15 (-1.61%)
At close: Jul 24, 2026, 4:00 PM EDT
9.18
+0.01 (0.11%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Corbus Pharmaceuticals Holdings Employees
Corbus Pharmaceuticals Holdings had 36 employees as of December 31, 2025. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$2,348,000
Market Cap
169.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 36 | 8 | 28.57% |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Dec 31, 2023 | 19 | -14 | -42.42% |
| Dec 31, 2022 | 33 | -8 | -19.51% |
| Dec 31, 2021 | 41 | -35 | -46.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 164 |
| Tonix Pharmaceuticals Holding | 142 |
| Tenaya Therapeutics | 70 |
| Pyxis Oncology | 56 |
| OnKure Therapeutics | 45 |
| AN2 Therapeutics | 21 |
| Equillium | 15 |
CRBP News
- 19 days ago - Corbus Pharmaceuticals appoints Viana Nicacio as chief medical officer - TheFly
- 19 days ago - Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho - TheFly
- 5 weeks ago - Corbus Pharmaceuticals price target lowered to $52 from $54 at Oppenheimer - TheFly
- 7 weeks ago - Corbus Pharmaceuticals Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Corbus Pharmaceuticals Holdings Slides: FY 2026 - Filings
- 7 weeks ago - Corbus Pharmaceuticals Holdings Transcript: KOL event - Transcripts
- 2 months ago - Corbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush - TheFly